IOPtima Ltd.

IOPtima Ltd. of Ramat Gan, Israel, has completed the three-month follow-up period for its initial human clinical study using the OT134 device. The laser-based therapy enables eye surgeons to operate and reduce internal eye pressure without penetrating the ocular membrane. So far, the results suggest that the laser filtration system may be a viable alternative to current glaucoma therapies.





LATEST NEWS

• The Winds of Change Are Blowing Through the Photonics Industry
  May 3, 2024
• PsiQuantum to Build Utility-Scale Quantum Computer in Australia
  May 3, 2024
• Tyndall, MIT Partner on Sustainable Chip Production Processes: Week in Brief: 5/3/24
  May 3, 2024
• Headwall Taps Jim Gareau to Lead Optical Components and Assemblies Unit
  May 2, 2024
• Cognex Names Former Siemens VP Dennis Fehr CFO
  May 2, 2024
• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024